SCHEMBL2836717

SCHEMBL2836717

CCN1Cc2ccoc2C(Oc2ccc(Cl)c(Cl)c2)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.35
SLC6A4 P31645 3/20 0.35
SLC6A3 Q01959 3/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM4E B2RXH2 3/20 0.34
CYP2D6 P10635 2/20 0.34
KCNH2 Q12809 2/20 0.34
CYP1A1 P04798 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
ALDH1A1 P00352 3/20 0.33
SIGMAR1 Q99720 1/20 0.33
HPGD P15428 1/20 0.32
DUSP3 P51452 1/20 0.32
PTPN5 P54829 1/20 0.32
PTPN11 Q06124 1/20 0.32
CCR3 P51677 3/20 0.32
HRH1 P35367 2/20 0.32
OPRK1 P41145 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2839442 0.84 SLC6A4 (0.38) SLC6A2SLC6A4SLC6A3MEN1KMT2A
Hydrochloric Acid SCHEMBL2837917 0.83 SLC6A4 (0.37) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL2838001 0.78 KDM4E (0.38) SLC6A2SLC6A4SLC6A3KDM4EALDH1A1
SCHEMBL2838043 0.76 SLC6A2 (0.35) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL2836972 0.75 SLC6A4 (0.34) SLC6A2SLC6A4SLC6A3KCNH2ALDH1A1
SCHEMBL2838307 0.73 KDM4E (0.38) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL2841039 0.73 ALDH1A1 (0.32) KMT2AKDM4EALDH1A1
Hydrochloric Acid SCHEMBL2837155 0.72 KDM4E (0.37) SLC6A2SLC6A4SLC6A3MEN1KMT2A
SCHEMBL2842479 0.72 SLC6A2 (0.49) SLC6A2SLC6A4SLC6A3CYP2D6KCNH2
Citric Acid SCHEMBL2835076 0.71 KDM4E (0.38) MEN1KMT2AKDM4EKCNH2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 SLC6A2 196/4885SLC6A4 185/4885SLC6A3 118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.